Suscribirse

Incorrect Overdose Management Advice in the Physicians' Desk Reference - 11/09/11

Doi : 10.1016/S0196-0644(97)70277-4 
Walter H Mullen, PharmD*, Ilene B Anderson, PharmD*, Susan Y Kim, PharmD*, Paul D Blanc, MD, MSPH§, Kent R Olson, MD*‡

Abstract

Study hypothesis: Physicians may consult references such as Physicians' Desk Reference (PDR) for overdose management advice. Although PDR recommendations are approved by the US Food and Drug Administration (FDA), we hypothesized that they are often outdated and potentially hazardous. Methods: We surveyed physicians who consulted our poison center during a 1-month period with regard to their use of the PDR for overdose information and also compared PDR overdose treatment recommendations with those of five current major toxicology references. For the PDR overdose information review, we examined data from the American Association of Poison Control Centers to identify pharmaceutical categories with the largest number of deaths. We reviewed the four leading drugs with at least 1,000 reported exposures in each category and identified 20 PDR-listed brand-name products for analysis. We obtained the consensus from five current toxicology references on contraindicated treatments, ineffective treatments, and specific recommended treatments or antidotes. Finally, we compared the overdose management advice provided in the 1994 PDR with the toxicology reference consensus. Results: Forty of 80 of physicians surveyed (50%) reported use of the PDR for overdose information in the preceding 12 months. Of the 20 PDR entries, 16 (80%) had at least one deficiency, and 5 (25%) had two or more deficiencies. Thirteen (65%) omitted an indicated specific treatment, three (15%) recommended contraindicated treatments, and four (20%) advised ineffective treatments with potential for harm. Only four entries (20%) had no deficiencies by our survey criteria. Conclusion: We found serious discrepancies in overdose treatment advice in the PDR compared with a consensus of current toxicology references. Altogether, four of five PDR entries were deficient, and almost half advised ineffective or frankly contraindicated therapies. Despite FDA approval, the use of PDR overdose advice in a serious poisoning case could result in unnecessary morbidity or mortality. [Mullen WH, Anderson IB, Kim SY, Blanc PD, Olson KR: Incorrect overdose management advice in the Physicians' Desk Reference. Ann Emerg Med February 1997;29:255-261.]

El texto completo de este artículo está disponible en PDF.

Esquema


 From the Schools of Pharmacy* and Medicine and the Division of Occupational and Environmental Medicine, School of Medicine§, University of California; and the San Francisco Bay Area Regional Poison Control Center, San Francisco, California.
 Address for reprints: Walter H Mullen, PharmD, San Francisco Bay Area Regional Poison Control Center, San Francisco General Hospital, Room 1E86, 1001 Potrero Avenue, San Francisco, California 94110, 415-206-8058, Fax 415-821-8513, E-mail w@wtnx.com
 Reprint no. 47/1/77729


© 1997  Mosby, Inc. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 29 - N° 2

P. 255-261 - février 1997 Regresar al número
Artículo precedente Artículo precedente
  • Hazardous Materials Exposure Information Service: Development, Analysis, and Medical Implications
  • Jefferey L Burgess, Matthew C Keifer, Scott Barnhart, Mary Richardson, William O Robertson
| Artículo siguiente Artículo siguiente
  • Refractory Asthma, Part 1: Epidemiology, Pathophysiology, Pharmacologic Interventions
  • Andy Jagoda, Suzanne Moore Shepherd, Antoinette Spevitz, Madeline M Joseph

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.